It is called a targeted therapy since it exclusively targets the CD38  which are overexpressed over the multiple myeloma cells. Daratumumab is from a class of medicines referred to as CD38 monoclonal antibodies. Always consult your healthcare supplier to ensure the information shown on this web page applies to your individual situation.If a plann